Fly News Breaks for February 27, 2020
Feb 27, 2020 | 07:45 EDT
Guggenheim analyst Glen Santangelo upgraded Rite Aid to Neutral from Sell and removed his prior $12 price target ahead of the company's upcoming analyst day. Given what he sees as "very low expectations," Santangelo believes management will outline a number of accomplishments and strategic initiatives that may be well received by investors, he tells investors. While a "large part" of the bear thesis has revolved around the upcoming "2023 debt wall, he believes the company is taking appropriate steps to restructure, Santangelo added.
News For RAD From the Last 2 Days
There are no results for your query RAD